Haleos Labs Ltd.
HALEOSLABS Share PricePharmaceuticals & Drugs
₹1,315.1
-41.4 (-3.1%)
As on December 4, 2025
Exchange Scrips: BSE540679NSEHALEOSLABSISININE320X01016
Market Cap ₹ 417 Cr
P/E Ratio 19.77
Dividend Yield 0.01 %
Performance
Market performance
Open1,356.5
High1,370
Volumes599
Prev1,315.1
Low1,306
As on2025-12-04
Historical performance
1 Year High1,680
3 Year High1,749.65
5 Year High1,749.65
1 Year Low959.8
3 Year Low472.05
5 Year Low469.75
Fundamentals
Company Valuation
Market Cap (₹Cr)
417
Face Value (₹)
10
P/E Ratio
19.77
Dividend Yield
0.01 %
Investment Returns
1 Year
12.8%
3 Years
105.8%
5 Years
100%
10 Years
N/A
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 1,365.12 | Bearish |
| 10-DMA | 1,371.09 | Bearish |
| 20-DMA | 1,320.75 | Bearish |
| 50-DMA | 1,220.94 | Bullish |
| 100-DMA | 1,189.01 | Bullish |
| 200-DMA | 1,208.27 | Bullish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 12 | 12 | 12 | 13 | 13 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 12 | 12 | 12 | 13 | 13 |
| Public Investors | 7509 | 7400 | 7467 | 7613 | 7836 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 19.77.
- 3Y Stock Price CAGR of the stock is 26.9.
- The stock has a beta of 0.9.
- In the last financial year, the company had an EBITDA of ₹500 Million.
- The company generated revenue of ₹3447 Million in the previous financial year.
Haleos Labs Ltd.
1315.1-41.4 (-3.1%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1126906.6
No. of Shares: 857 (Approx)
Performance:12.7%
P/L: ₹126906.6
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
